The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index; none of the 46 sources its claims cite is checked for support yet.
Antidepressant withdrawal – the tide is finally turning
Open accessAbstract
Withdrawal reactions when coming off antidepressants have long been neglected or minimised. It took almost two decades after the selective serotonin reuptake inhibitors (SSRIs) entered the market for the first systematic review to be published. More reviews have followed, demonstrating that the dominant and long-held view that withdrawal is mostly mild, affects only a small minority and resolves spontaneously within 1–2 weeks, was at odd with the sparse but growing evidence base. What the scientific literature reveals is in close agreement with the thousands of service user testimonies available online in large forums. It suggests that withdrawal reactions are quite common, that they may last from a few weeks to several months or even longer, and that they are often severe. These findings are now increasingly acknowledged by official professional bodies and societies.
Overview
CoChat Summary
TL;DR
This editorial argues that antidepressant withdrawal has long been neglected or minimised, but recent reviews indicate it is common, often severe, and sometimes prolonged. It calls for revised treatment guidelines and better recognition and management of withdrawal, noting that official bodies such as the Royal College of Psychiatrists and NICE are beginning to change position.
Key findings
- Four reviews converged on withdrawal reactions affecting between 30 and 60% of antidepressant users when they try to come off, with estimates varying by methodology and drug elimination half-life.
- Duration is highly variable: withdrawal lasted over 2 weeks in 55% of patients, at least 12 weeks in 25%, and a mean of 43 days in one study; two community samples reported durations over a year in 38.6% and a mean of 90.5 weeks.
- Just under half of affected people (46%) rated their withdrawal as severe, according to Davies and Read’s systematic review.
- The paper disputes claims that withdrawal mainly follows abrupt discontinuation or resolves in 1–2 or 2–3 weeks, arguing that even gradual tapers over a few weeks may not substantially reduce risk.
Methods
- Design: editorial/commentary providing a narrative synthesis of evidence on antidepressant withdrawal, not a primary research study.
- Data/sample: no original sample; it draws on four systematic reviews (Fava et al. 2015, 2018; Jha et al. 2018; Davies and Read 2019a) plus other studies, surveys, and community reports.
- Main analysis: narrative comparison of incidence, severity, and duration estimates, critique of guideline positions and published critiques, and discussion of clinical and policy implications.
Limitations
- The paper states no limitations.
- Evident from the text: it is a commentary/editorial rather than a systematic review, so it does not report a systematic search strategy, formal quality appraisal, or primary data analysis.
- Evident from the text: its conclusions depend on the cited reviews and selected evidence, and it is explicitly advocacy-oriented, urging guideline revision and acknowledging professional controversy.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 1 Not valid · 30 Not checked · 8 Own results and interpretations
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Withdrawal reactions when coming off antidepressants have long been neglected or minimised.”
- Also stated in: § Abstract · plain
“Firstly, the psychiatric profession has started to acknowledge that these serious issues have long been neglected and minimised.”
§ Antidepressant withdrawal – the tide is finally turning > Abstract
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · plain
None of the sources cited for this claim have been checked yet.
In the paper
“short-term randomised-controlled trials based on pre-selected participants produced somewhat lower estimates than more representative naturalistic studies and large surveys including many long-term users”
§ Antidepressant withdrawal – the tide is finally turning > Abstract
What the sources say
- Not checked yetcites Fava et al., 2015
- Not checked yetcites Davies and Read, 2019a
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Although controlled clinical trials and observational studies have revealed remarkably high rates of withdrawal reactions emerging shortly after discontinuation (Rosenbaum et al., 1998; Sir et al., 2005; Fava et al., 2007), the preferred narrative in academic psychiatry has always been that withdrawal problems affect only a small minority, are mostly mild and resolve spontaneously within 1–2 weeks”
§ Antidepressant withdrawal – the tide is finally turning > Abstract
What the sources say
- Not checked yetcites Rosenbaum et al., 1998
- Not checked yetcites Sir et al., 2005
- Not checked yetcites Fava et al., 2007
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Common withdrawal symptoms include anxiety, irritability, agitation, dysphoria, insomnia, fatigue, tremor, sweating, shock-like sensations (‘brain zaps’), paraesthesia, vertigo, dizziness, nausea, vomiting, confusion and decreased concentration (Fava et al., 2015).”
§ Antidepressant withdrawal – the tide is finally turning > Abstract
What the sources say
- Not checked yetcites Fava et al., 2015
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Like most other central nervous system drugs, including benzodiazepines, alcohol or heroin, selective serotonin reuptake inhibitor (SSRI) antidepressants may cause withdrawal reactions upon discontinuing the drug, especially after prolonged use (Nielsen et al., 2012; Chouinard and Chouinard, 2015).”
§ Antidepressant withdrawal – the tide is finally turning > Abstract
What the sources say
- Not checked yetcites Nielsen et al., 2012
- Not checked yetcites Chouinard and Chouinard, 2015
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
25 more claims
Create a free account to see all 39 claims and to verify the 46 references still open.
- It may state two separate claims as one. 5
- Probably not a substantial claim. 4
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A possible driver of unnecessary long-term medication could be the propensity of antidepressants to cause physical dependence (i.e., pharmacodynamic neurophysiological adaptations) and withdrawal symptoms upon dose reduction or cessation discouraging discontinuation.11–18”
From Protracted withdrawal syndrome after stopping antidepressants: a descriptive quantitative analysis of consumer narratives from a large internet forum (2020) · cites this paper as [15]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, in due course after their introduction, more pronounced problems occurred with most of the newer antidepressants.40–46”
From May antidepressant drugs worsen the conditions they are supposed to treat? The clinical foundations of the oppositional model of tolerance (2020) · cites this paper as [46]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It would seem that, with both types of drugs, that withdrawal reactions and post-withdrawal syndromes may ensue, despite slow tapering.”
From May antidepressant drugs worsen the conditions they are supposed to treat? The clinical foundations of the oppositional model of tolerance (2020) · cites this paper as [46]
Experimental — accuracy not yet measuredIn the citing paper
“Like venlafaxine and paroxetine, duloxetine has a short half-life, which does make it harder to withdraw from.11,19,42–44”
In the citing paper
“Unfortunately, until very recently, medical associations, pharmaceutical companies, drug regulators, psychiatric academics, and practitioners have largely neglected or minimized this serious public health issue.15,16,68,69”
From Protracted withdrawal syndrome after stopping antidepressants: a descriptive quantitative analysis of consumer narratives from a large internet forum (2020) · cites this paper as [15]
Citations
Cites
Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial
Rosenbaum, J. F., Fava, M., Hoog, S. L., Ascroft, R. C., & Krebs, W. B. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00126-7 · Cited by 574 · cited 3×
“Although controlled clinical trials and observational studies have revealed remarkably high rates of withdrawal reactions emerging shortly after discontinuation (Rosenbaum et al., 1998; Sir et al., 2005; Fava et al., 2007), the preferred narrative in academic psychiatry has always been that withdrawal problems affect…”
BackgroundFava, G. A., Gatti, A., Belaise, C., Guidi, J., & Offidani, E. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000370338 · Cited by 436 · cited 5×
“…Fava and colleagues maintained that even the common gradual tapers over a few weeks could not substantially reduce the risk of withdrawal reactions (Fava et al., 2015; Fava and Cosci, 2019), a view also supported by recent work published in Lancet Psychiatry, where withdrawal can span over…”
BackgroundResultInfluentialInfluences on antidepressant prescribing trends in the UK: 1995–2011
Mars, B., Heron, J., Kessler, D., Davies, N. M., Martin, R. M., Thomas, K. H., & Gunnell, D. (2017) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-016-1306-4 · Cited by 419 · cited 1×
“The duration of antidepressant usage has steadily increased over the years (Huijbregts et al., 2017; Mars et al., 2017), while large proportions of users indicate that they feel ‘addicted’ to the drugs and experience withdrawal effects (Kessing et al.”
BackgroundDavies, J., & Read, J. (2019) · Addictive Behaviors · doi:10.1016/j.addbeh.2018.08.027 · Cited by 387 · cited 8×
“Two further reviews have recently been published (Jha et al., 2018; Davies and Read, 2019a).”
BackgroundResultInfluentialSelf-citationAntidepressant discontinuation reactions: Are preventable and simple to treat
Haddad, P., Lejoyeux, M., & Young, A. (1998) · BMJ · doi:10.1136/bmj.316.7138.1105 · Cited by 286
Tapering of SSRI treatment to mitigate withdrawal symptoms
Horowitz, M. A., & Taylor, D. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30032-x · Cited by 280 · cited 6×
“, 2015; Fava and Cosci, 2019), a view also supported by recent work published in Lancet Psychiatry, where withdrawal can span over extensive tapering periods (Horowitz and Taylor, 2019).”
BackgroundResultInfluentialAntidepressant Discontinuation Syndromes: Clinical Relevance, Prevention and Management
Haddad, P. M. (2001) · Drug Safety · doi:10.2165/00002018-200124030-00003 · Cited by 214 · cited 1×
“Since then, withdrawal reactions were sporadically studied and discussed in the scientific literature (e.g. Rosenbaum et al., 1998; Haddad, 2001; Baldwin et al., 2007).”
BackgroundFava, G. A., Benasi, G., Lucente, M., Offidani, E., Cosci, F., & Guidi, J. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000491524 · Cited by 209 · cited 1×
“A few years after their SSRI review, Fava and colleagues also published a systematic review on serotonin-norepinephrine reuptake inhibitor withdrawal (Fava et al., 2018).”
BackgroundRead, J., & Williams, J. (2018) · Current Drug Safety · doi:10.2174/1574886313666180605095130 · Cited by 175 · cited 2×
“…duration of antidepressant usage has steadily increased over the years (Huijbregts et al., 2017; Mars et al., 2017), while large proportions of users indicate that they feel ‘addicted’ to the drugs and experience withdrawal effects (Kessing et al., 2005; Read and Williams, 2018; Read et al., 2018).”
BackgroundSelf-citationNew Classification of Selective Serotonin Reuptake Inhibitor Withdrawal
Chouinard, G., & Chouinard, V.-A. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000371865 · Cited by 164 · cited 1×
“Like most other central nervous system drugs, including benzodiazepines, alcohol or heroin, selective serotonin reuptake inhibitor (SSRI) antidepressants may cause withdrawal reactions upon discontinuing the drug, especially after prolonged use (Nielsen et al., 2012; Chouinard and Chouinard, 2015).”
Background
Research works printed but not linked: 2
- 2009, Depression in Adults: Recognition and Management
- 2010, Practice Guideline for the Treatment of Patients with Major Depressive Disorder
Cited by
Van Leeuwen, E., van Driel, M. L., Horowitz, M. A., Kendrick, T., Donald, M., De Sutter, A. I., Robertson, L., & Christiaens, T. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013495.pub2 · Cited by 90
Fava, G. A. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320970325 · Cited by 84
Hengartner, M. P., Schulthess, L., Sorensen, A., & Framer, A. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320980573 · Cited by 74
Self-citationHengartner, M. P. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320921694 · Cited by 72
Self-citationAttenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use
Gukasyan, N., Griffiths, R. R., Yaden, D. B., Antoine, D. G., & Nayak, S. M. (2023) · Journal of Psychopharmacology · doi:10.1177/02698811231179910 · Cited by 67
“Antidepressant discontinuation is associated with relapse and withdrawal phenomena that may put patients at risk of serious harm (Gemma et al., 2021; Hengartner et al., 2020).”
Background
Metadata
- Authors
- Hengartner, M. P., Davies, J., & Read, J.
- Affiliations
- ZHAW Zurich University of Applied Sciences (CH)
- Parliament of United Kingdom (GB)
- University of East London (GB)
- Corresponding author
- Hengartner, Michael P.
- Venue
- Epidemiology and Psychiatric Sciences
- Publisher
- Cambridge University Press (CUP)
- Published
- 2019-08-22
- Volume
- 29
- Pages
- e52-e52
- ISSN
- 2045-7960 (ISSN-L)
- 2045-7979
- PMC
- PMC8061160
- OpenAlex
- W2969982843
- Cited by
- 48
- References
- 35
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 10 · 2023: 10 · 2022: 8 · 2021: 7 · 2020: 4 · 2019: 1
- FWCI
- 3.10
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Epidemiology and Psychiatric Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Zürcher Hochschule für Angewandte Wissenschaften digital collection (Zurich University of Applied Sciences) (submittedVersion, cc-by-nc-nd)
- UEL Research Repository (University of East London) (submittedVersion, cc-by)
- ZHAW Digital Collection (cc-by)
- Funders
- Royal College of Psychiatrists
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Keywords
- antidepressant discontinuation, selective serotonin reuptake inhibitors, withdrawal symptoms, professional guidelines
- MeSH terms
- Serotonin and Noradrenaline Reuptake Inhibitors, Antidepressive Agents, Humans, Severity of Illness Index, Substance Withdrawal Syndrome, Selective Serotonin Reuptake Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antidepressant withdrawal – the tide is finally turning. https://app.cochat.ai/papers/10.1017/s2045796019000465
- The paper
- Hengartner, M. P., Davies, J., & Read, J. (2020). Antidepressant withdrawal – the tide is finally turning. Epidemiology and Psychiatric Sciences. https://doi.org/10.1017/s2045796019000465
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.